KRASP | KRAS Somatic Mutation Analysis, Tumor

This test is intended for detecting molecular markers associated with response or resistance to specific cancer.

MALCT | Plasmodium Percent Parasitemia Reflex, Varies

This test is intended for calculation of percent parasitemia that can be used to predict prognosis and monitor response to treatment for patients with malaria.

HSTQU | Histoplasma Antigen, Quantitative Enzyme Immunoassay, Random, Urine

This test is intended for aiding in the diagnosis of Histoplasma capsulatum infection, and monitoring Histoplasma antigen levels in urine.

IODCU | Iodine/Creatinine Ratio, Random, Urine

This test is intended for assessment of iodine toxicity or recent iodine exposure in a random urine collection, and monitoring iodine excretion rate as index of replacement therapy.

HIBSG | Haemophilus influenzae Type B Antibody, IgG, Serum

This test is intended for assessing a patient's immunological (IgG) response to Haemophilus influenzae& type B (HIB) vaccine, assessing immunity against HIB, and aiding in the evaluation of immunodeficiency when the patient is tested pre- and post-vaccination.

NF4FS | Neurofascin-155 IgG4, Flow Cytometry, Serum

This test is intended for evaluating patients with an underlying demyelinating neuropathy, and diagnosis of a neurofascin-155 IgG4 mediated neuropathy.

IN16Q | CBFB-MYH11 Inversion(16), Quantitative Detection and Minimal Disease Risk Monitoring, qRT-PCR, Varies

This test is intended for detection of CBFB-MYH11 gene fusion in patients recently diagnosed with acute myeloid leukemia (AML) and, minimal residual disease monitoring during the clinical and therapeutic course of patients with AML.